2025 · 1st Quarter (Jan 1 - Mar 31)
Filed by F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES.
Open official filingSource-reported fields
Expense method: A
Literal source text
(HCR) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics
Literal federal measure citations: H.R.1108
(MED) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Clinical Lab Fee Schedule reform and Medicare coverage of FDA approved breakthrough diagnostics and innovative diagnostics
Literal federal measure citations: H.R.1108
(MMM) Clinical Lab Fee Schedule reform and Medicare coverage of FDA approved breakthrough diagnostics and innovative diagnostics (preeclampsia)
(FOR) PEPFAR Reauthorization / FY2026 Appropriations for PEPFAR laboratory services and testing
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
